Abstract
Background: Ovarian cancer (OC) commonly involves the peritoneal cavity and carries a high recurrence rate despite surgical excision and systemic therapy. Cytoreductive Surgery (CRS) and Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) have shown to improve outcomes in a recent multicenter randomized controlled trial. We evaluate the outcomes of patients with OC that underwent CRS and HIPEC at a single institution.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
